KITLG and Cognitive impairment: Further investigation into the metabolome of cognitive stimulation, along with understanding how KL1 mimics this metabolome and ultimately improves brain function, opens pathways to pharmacologic interventions to enhance normal cognition and counter cognitive deficits from aging and disease.